NO20024289D0 - Preparat for behandling av hjertesvikt - Google Patents

Preparat for behandling av hjertesvikt

Info

Publication number
NO20024289D0
NO20024289D0 NO20024289A NO20024289A NO20024289D0 NO 20024289 D0 NO20024289 D0 NO 20024289D0 NO 20024289 A NO20024289 A NO 20024289A NO 20024289 A NO20024289 A NO 20024289A NO 20024289 D0 NO20024289 D0 NO 20024289D0
Authority
NO
Norway
Prior art keywords
treatment
disorders
preparation
viral
heart disorders
Prior art date
Application number
NO20024289A
Other languages
English (en)
Other versions
NO20024289L (no
Inventor
Elizabeth Louise Jones
Original Assignee
Medinnova Sf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0005867.7A external-priority patent/GB0005867D0/en
Priority claimed from GB0027661A external-priority patent/GB0027661D0/en
Application filed by Medinnova Sf filed Critical Medinnova Sf
Publication of NO20024289D0 publication Critical patent/NO20024289D0/no
Publication of NO20024289L publication Critical patent/NO20024289L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20024289A 2000-03-10 2002-09-09 Preparat for behandling av hjertesvikt NO20024289L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0005867.7A GB0005867D0 (en) 2000-03-10 2000-03-10 Method
GB0027661A GB0027661D0 (en) 2000-11-13 2000-11-13 Method
PCT/GB2001/001054 WO2001066124A2 (en) 2000-03-10 2001-03-09 Composition for the treatment of heart failure

Publications (2)

Publication Number Publication Date
NO20024289D0 true NO20024289D0 (no) 2002-09-09
NO20024289L NO20024289L (no) 2002-11-11

Family

ID=26243851

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024289A NO20024289L (no) 2000-03-10 2002-09-09 Preparat for behandling av hjertesvikt

Country Status (8)

Country Link
EP (1) EP1267905B1 (no)
JP (1) JP2003525905A (no)
AT (1) ATE305311T1 (no)
AU (1) AU4079001A (no)
CA (1) CA2400504A1 (no)
DE (1) DE60113664T2 (no)
NO (1) NO20024289L (no)
WO (1) WO2001066124A2 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR101600A0 (en) * 2000-10-25 2000-11-16 Atheromastat Pty Ltd Compositions and methods for diagnosis and treatment of cardiovascular disorders
AUPS194902A0 (en) * 2002-04-24 2002-06-06 Atheromastat Pty Ltd Compositions and methods for diagnosis and treatment of cardiovascular disorders
US20030223985A1 (en) * 2002-05-29 2003-12-04 The Lauridsen Group. Incorporated Globulin protein to lower cholesterol in humans
EP1755642B1 (en) * 2004-04-15 2010-01-13 Athera Biotechnologies Ab Annexin v for preventing plaque rupture
US8025634B1 (en) * 2006-09-18 2011-09-27 Baxter International Inc. Method and system for controlled infusion of therapeutic substances
GB0717637D0 (en) * 2007-09-10 2007-10-17 Univ Leiden Future cardiac event biomarkers
US20100316563A1 (en) * 2007-09-20 2010-12-16 Bracco Imaging S.P.A. Method For The Preparation Of New Oligoclonal Antibodies
EP2230251A1 (en) * 2009-03-19 2010-09-22 Bracco Imaging S.p.A Antibodies specifically active in the coronary plaque and method for their identification
EP2831586B1 (en) 2012-03-26 2021-09-29 XCellCure, LLC Device and method for detection of analytes
US10087238B2 (en) 2017-02-22 2018-10-02 Kuwait University Method of preventing myocardial reperfusion injury in reperfusion therapy by administering intravenous immunoglobulin
KR102549282B1 (ko) * 2019-11-18 2023-06-30 건국대학교 산학협력단 시알산화된 면역글로불린을 유효성분으로 포함하는 염증성 질환의 치료용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800078A (en) * 1987-05-28 1989-01-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
CA2161349A1 (en) * 1993-06-11 1994-12-22 Denis Glotz Immunoglobulin infusion in xenotransplantation
US5562902A (en) * 1994-03-14 1996-10-08 Arp Biomed, Inc. Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin
HU228076B1 (en) * 1998-06-09 2012-10-29 Csl Behring Ag Process for producing immunoglobulins for intravenous administration and other immunoglobulin products

Also Published As

Publication number Publication date
DE60113664D1 (de) 2006-02-09
EP1267905A2 (en) 2003-01-02
ATE305311T1 (de) 2005-10-15
JP2003525905A (ja) 2003-09-02
DE60113664T2 (de) 2006-07-06
AU4079001A (en) 2001-09-17
CA2400504A1 (en) 2001-09-13
EP1267905B1 (en) 2005-09-28
WO2001066124A3 (en) 2002-03-28
WO2001066124A2 (en) 2001-09-13
NO20024289L (no) 2002-11-11

Similar Documents

Publication Publication Date Title
DE60114994D1 (de) Blutplättchen-adp-rezeptor-inhibitoren
TR200000561T2 (tr) Amlodipin ve atorvastatin içeren tedavisel bileşikler.
DE60143393D1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
ATE403430T1 (de) Neue carbamate- und harnstoffderivate als mittel gegen multidrugresistenz
NO20033862L (no) Fremgangsmåte for prevensjon eller terapi av inflammatoriske eller autoimmune lidelser ved administrering av integrin-alfa-beta3-antagonisteri kombinasjonmed andre profylaktiske eller terapeutiske midler
ATE485290T1 (de) Platelet adp rezeptor inhibitoren
NO20024289D0 (no) Preparat for behandling av hjertesvikt
NO20060328L (no) Kombinasjon av mGluR2-antagonist og ACHE-inhibitor for behandiing av akutt og/eller kronisk neurologiske forstyrrelser
ITRM990338A0 (it) Composizione dietetica o farmaceutica utile per la prevenzione o il trattamento dell'iperossaluria.
NO20041070L (no) Preparat for behandling av vanlig forkjolelse.
NO20052739L (no) CCR5-antagonister som medikamenter
DK1202736T3 (da) Nikotin i terapeutisk angiogenese og vasculogenese
BR0308739A (pt) Tratamentos em combinação para doenças mediadas por quimiocina
WO2004020410A3 (en) Dihydropyridinone derivatives as hne inhibitors
WO2003053349A3 (en) Inhibitors of hepatitis c virus
TR200100377T2 (tr) Aß Protein üretimi inhibitörleri olarak sukinoilamino laktamlar.
HUP0401614A2 (hu) PDE4 inhibitort és antikolinerg hatóanyagot tartalmazó gyógyszerkészítmények és alkalmazásuk
SE9903759D0 (sv) Pharmaceutically active compounds
ATE202776T1 (de) Piperinderivate als neurokininantagoniste
DZ2752A1 (fr) Composés et compositions pharmaceutiques pour le traitement du paludisme.
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
WO2003082196A3 (en) Combination therapy using trefoil peptides
SE0101932D0 (sv) Pharmaceutical combinations
EP1195166A3 (en) Use of a vasopressin antagonist such as conivaptan in the manufacture of a medicament for treating pulmonary hypertension
WO2002085358A3 (en) Antiviral agents and methods of treating viral infections

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application